Valutazione Del Benessere Psico-Fisico Nell’aderenza Terapeutica Nelle Donne Con Malattia Renale Policistica Autosomica Dominante: Uno Studio Osservazionale

Abstract

Evaluation Of The Psychophysical Well-Being In The Compliance Of Women With Autosomal Dominant Policystic Kidney Disease: An Observational Study

BACKGROUND: Autosomal dominant polycystic kidney disease is the most common inherited renal disease and affects less than 1 every 400-1,000 people. There are many effective treatments, including blood pressure management, physical activity, low sodium diet and hydration. Therapeutic education is part of a patient’s care and treatment. This approach is an essential strategy in order to face the current healthcare scenario, in which the number of people affected by chronic diseases is progressively increasing. OBJECTIVES: This article aims to analyze the effect of therapeutic education in patients with ADPKD, the level of adherence to pharmacological therapy and their compliance to dietetic and lifestyle recommendations as part of a nursing-led education. METHODS: This is a prospective, longitudinal, observational pilot study. The following measurements were used: Kidney Disease Quality of life - Short Form, Hospital Anxiety and Depression Scale, Body Uneasiness Test. At the T0 visit, a nurse selected patients and carried out a personalized educational intervention with the aims of adhering to drug therapies, monitoring blood pressure and dietary behavior (physical activity and water intake). At the T1 visit, patients performed psychological tests. At the T2 visit, the following evaluations were performed: a psychological interview together with the delivery and evaluation of the tests performed, an interview with the nurse to evaluate the adherence to the prescriptions, and a control of parameters such as physical activity, diet, water intake, drug therapy, and blood pressure. RESULTS: Therapeutic education can have a positive impact on patients’ health by improving adherence to the pharmacological therapy, diet and lifestyle. CONCLUSIONS: Therapeutic education improve the patient’s knowledge, treatments and correct behaviors as well as promotes an independent management of the disease. Through an educational intervention, the patient acquires the ability and the awareness to modify the wrong behaviors and to guarantee a balance between his needs and the pathology, thus improving the quality of life.

Keywords

Therapeutic adherence Autosomal dominant polycystic kidney disease Lifestyle Therapeutic education Physical activity Diet

Get full access to this article

View all access options for this article.

References

Pei

Watnick

Diagnosis and screening of autosomal dominant polycystic kidney disease. Advance in Chronic Kidney Disease. 2010; 17(2):140–152.

Chapman

AB.

Cystic disease in women: clinical characteristic and Medical Management. Advances in Renal Replacement Therapy. 2003; 10(1):24–33.

KDIGO. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int. 2012; (3):1–150.

Simms

Thong

Dworschak

, et al. Increased Psychosocial Risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2016; 31(7):1130–1140.

Lecourt

. Serious somatic disease as a limit-experience: clinical aspect of end-stage renal disease. Soins. 2018; 63(826):43–45.

Pierobon

Giardini

Callegari

, et al. Psychological adjustment to a chronic illness: the contribution from cognitive behavioral treatment in a rehabilitation setting. Giornale Italiano Medicina del Lavoro ed Ergonomia. 2011; 33(1):8–11.

Miskulin

Abebe

Chapman

, et al. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1- 4: a cross-sectional study. Am J Kidney Dis. 2014; (63):214–226.

Pérez Domìnguez

Rodriguez Perez

Buset Rios

, et al. Psychonephrology: psychological aspects in autosomal dominant polycystic kidney disease. Nephrology. 2011; (31):716–722.

Kimmel

Patel

SS.

Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Semi Nephrol. 2006; (26):68–79.

10.

Tran

Huynh

Chan

Chesla

, et al. Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease. BMC Nephrol. 2017; 18(5):214.

11.

Cowley

Jr. Bissler

JJ.

Polycystic Kidney Disease. New York: Springer 2018.

12.

WHO. Therapeutic Patient Education. Continuing Education Programs for Health Care Providers in the Field of Prevention of Chronic Diseases Report of a WHO Working Group. 1996.

13.

Xavier

Ferrazb

Marcc

, et al. Elderly people ́s definition of quality of life. Rev Bras Psiquiatr. 2003; vol.25(1):31–39.

14.

Burrai

Hasan

Luppi

, et al. A Conceptual Framework Encompassing the Psychoneuroimmunoendocrinological Influences of Listening to Music in Patients With Heart Failure. Holistic Nursing Practice. 2018; 32(2):81–89.

15.

Miselli

Il problema dell’adesione alla terapia in una malattia cronica come il diabete. G It Diabetol Metab. 2011; (31):121–124.

16.

Chapman

AB.

Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. Clin J Am Soc Nephrol. 2008; (3):1197–1204.

17.

Klersy

Callegari

Giorgi

, et al. Italian translation, cultural adaptation and validation of KDQOL-SF, version 1.3, in patients with severe renal failure. Journal of Nephrology. 2007; 20(1):43–51.

18.

Zigmond

Snaith

RP.

The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983; 67(6):361–370.

19.

Cuzzolaro

Vetrone

Marano

, et al. The Body Uneasiness Test (BUT): development and validation of a new body image assessment scale. Eating and Weight Disorders. 2006; 11(1):1–13.

20.

Cordier

JF.

The expert patient: towards a novel definition Respiratory Journal. 2014; (44):853– 857.